These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11309553)

  • 1. Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans.
    Enggaard TP; Klitgaard NA; Gram LF; Arendt-Nielsen L; Sindrup SH
    Clin Pharmacol Ther; 2001 Apr; 69(4):245-51. PubMed ID: 11309553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The analgesic effect of codeine as compared to imipramine in different human experimental pain models.
    Enggaard TP; Poulsen L; Arendt-Nielsen L; Hansen SH; Bjørnsdottir I; Gram LF; Sindrup SH
    Pain; 2001 May; 92(1-2):277-82. PubMed ID: 11323149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of gabapentin in human experimental pain models.
    Enggaard TP; Mikkelsen SS; Zwisler ST; Klitgaard NA; Sindrup SH
    Scand J Pain; 2010 Jul; 1(3):143-148. PubMed ID: 29913969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.
    Yucel A; Ozyalcin S; Koknel Talu G; Kiziltan E; Yucel B; Andersen OK; Arendt-Nielsen L; Disci R
    Eur J Pain; 2005 Aug; 9(4):407-16. PubMed ID: 15979021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial.
    Forssell H; Tasmuth T; Tenovuo O; Hampf G; Kalso E
    J Orofac Pain; 2004; 18(2):131-7. PubMed ID: 15250433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Gee MD; Krishen A; Wunderlich HP; Le Clus A; Evoniuk G; Modell JG
    J Psychopharmacol; 2010 Aug; 24(8):1209-16. PubMed ID: 19939870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)].
    Ansseau M
    Rev Med Liege; 1998 Feb; 53(2):106-8. PubMed ID: 9564231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of venlafaxine for the long term treatment of chronic pain with associated major depressive disorder.
    Bradley RH; Barkin RL; Jerome J; DeYoung K; Dodge CW
    Am J Ther; 2003; 10(5):318-23. PubMed ID: 12975715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of venlafaxine.
    Ballenger JC
    J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):29S-35S; discussion 35S-36S. PubMed ID: 8784646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of neuropathic pain with venlafaxine.
    Sumpton JE; Moulin DE
    Ann Pharmacother; 2001 May; 35(5):557-9. PubMed ID: 11346061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venlafaxine hydrochloride and chronic pain.
    Taylor K; Rowbotham MC
    West J Med; 1996 Sep; 165(3):147-8. PubMed ID: 8909172
    [No Abstract]   [Full Text] [Related]  

  • 14. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
    Augustin BG; Cold JA; Jann MW
    Pharmacotherapy; 1997; 17(3):511-30. PubMed ID: 9165554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyponatremia with venlafaxine.
    Masood GR; Karki SD; Patterson WR
    Ann Pharmacother; 1998 Jan; 32(1):49-51. PubMed ID: 9475820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venlafaxine: not yet first in the antidepressant class.
    Harv Ment Health Lett; 2003 Apr; 19(10):5-7. PubMed ID: 12711568
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis.
    Smith D; Dempster C; Glanville J; Freemantle N; Anderson I
    Br J Psychiatry; 2002 May; 180():396-404. PubMed ID: 11983635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular safety in depressed patients: focus on venlafaxine.
    Feighner JP
    J Clin Psychiatry; 1995 Dec; 56(12):574-9. PubMed ID: 8530334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.
    Thase ME; Entsuah AR; Rudolph RL
    Br J Psychiatry; 2001 Mar; 178():234-41. PubMed ID: 11230034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.